B.More Inc

Psychedelic medicine developer

B.More Inc. is a 501(c)(3) nonprofit drug-development organization focused on psilocybin programs for alcohol and other substance use disorders. Its pipeline includes an alcohol-use-disorder program with an FDA-cleared IND but unverified trial initiation, a proposed Phase 2b program, and a collaborative Phase 2 opioid-use-disorder study. The available information identifies B.More as a nonprofit and does not report a change in ownership. It is based in Greenwich, Connecticut; all candidates are investigational and are not available to buy.

B.More Inc catalog

All products · Psychedelic medicine pipeline

Shop the B.More Inc catalog

3 items across 1 shelf

Psychedelic medicine pipeline3 items

• SYNP-101 – Synthetic psilocybinInvestigational
• SYNP-102 – PsilocybinInvestigational
• Uncoded (NYU/NIDA collaborative study) – PsilocybinInvestigational